What Faba does

FABA CAPITAL a.s. (operating as Faba Capital) is a privately held venture capital and investment firm incorporated in the Czech Republic (headquartered at Varišavská 715/36, Praha 2; IČO 099 49 411). The firm invests in and operates a portfolio of companies in the Central and Eastern European region across healthcare, biotechnology, medical technology, assisted reproduction, nuclear energy, senior services, and digital health. Its portfolio/wholly-owned subsidiaries include Medical Meadow a.s. (premium medical care: surgery, dentistry, gynecology, general practice, assisted reproduction), FABA INCUBE a.s. (a Prague-based startup incubator bridging university research and industry, launched 4 May 2023), AGORA Pharmaceuticals s.r.o. (Alzheimer's-focused biotech, founded 2015), Fetus, IVF a.s. (assisted reproduction with patent-pending miRNA diagnostic/embryo-selection technology, acquired 31 January 2023), Grandsenior s.r.o. (online senior-care marketplace), and Teledoc/JSM Teledoc (online medical/therapeutic platform). The firm additionally holds a strategic position in the NAPOLEON HR-4F nuclear hydrogen project.

The investment approach is built around a stated CSR/ESG methodology for portfolio construction and a stated preference for innovative CEE projects with global ambition and positive societal impact. The firm does not publicly disclose pricing, AUM, or revenue. Its disclosed capital instruments include a $1.2M funding round dated 31 January 2019 (investor: C.C.T Consulting), and two corporate bond programs issued in late 2024 — FABA CAPITAL 12,25/28 (November 2024) and FABA CAPITAL 14,25/28 (December 2024) — each with published emission terms, guarantor declarations, and a December 2024 amendment supplement. Revenue mechanics therefore combine (i) equity returns and operating income from subsidiaries, (ii) bond-funded capital operations, and (iii) selective direct investment in early-stage projects.

The firm is led by CEO and founder Robert Flocius, with Roman Valovič as Marketing Director and Petr Čihák as CEO of FABA INCUBE. Go-to-market is primarily direct outreach to CEE startups, supported by Czech/Slovak-language content marketing (blog) and press releases tied to portfolio milestones. The customer base is dual-sided: portfolio-company investees on one side, and the end-user customer bases of the operating subsidiaries (medical patients, IVF patients, seniors, telehealth users) on the other. The firm operates from a single headquarters in Prague with no disclosed additional offices despite the "UK" country tag in third-party firmographic data, which conflicts with the primary-source Czech HQ.

Name

Faba

Legal name

FABA CAPITAL a.s.

Website

https://fabacapital.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

FABA CAPITAL a.s. is a private Czech venture capital and investment firm that builds and backs a portfolio of innovative healthcare, biotech, nuclear-energy and senior-services companies across Central and Eastern Europe.

Ownership category

akta.pro rank

Product category

Venture Capital and Private Equity

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Investors, Nec (6799), Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Corporate M&A / Venture Build-to-Buy Programs (Acqui-hire, option-to-acquire) (FSANAHAG)

akta.pro secondary industry

Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL)

Keywords

• Venture capital investing
• Startup incubation services
• Portfolio company management
• Biotech investment funding
• CEE innovation financing

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Distribution channels1 record

Marketing channels3 records

Core offering

Faba Capital is a privately held venture capital and investment firm that invests in and supports innovative projects in the Central and Eastern European (CEE) region. The firm raises capital through bond emissions and direct investor outreach, then deploys it into a multi-sector portfolio spanning healthcare, biotechnology, assisted reproduction, nuclear energy, medical services, senior care, and startup incubation, providing portfolio companies with capital, due diligence, and strategic partnership support under CSR and ESG principles.

Product overview

FABA Capital is a venture capital investment firm that provides investment services to innovative projects in the Central and Eastern European (CEE) region with global ambitions. The company operates as a multi-project portfolio platform, supporting companies across healthcare sectors including biotech/pharmaceuticals (AGORA Pharmaceuticals), medical services (Medical Meadow, Teledoc), assisted reproduction (Fetus IVF), and deep tech (NAPOLEON HR-4F nuclear reactors). Additionally, FABA operates FABA INCUBE, a startup incubator for universities and research institutions, and maintains a marketplace for seniors (Grandsenior). The investment approach emphasizes CSR and ESG strategies with positive societal impact.

Differentiator

Problem solved

Functional benefit

Brands

• NAPOLEON HR-4F: Nuclear reactor concept - gas-cooled fast reactor IV generation focused on hydrogen production led by CEO Branislav Hatala
• AGORA Pharmaceuticals
• Medical Meadow
• FABA INCUBE
• Fetus IVF
• Grandsenior
• Teledoc

Products and services

• FABA Capital Venture Capital Investment
• Medical Meadow Premium Medical Care
• FABA INCUBE Startup Incubation
• Fetus, IVF Assisted Reproduction Services
• AGORA Pharmaceuticals Drug Development
• NAPOLEON HR-4F Nuclear Reactor Concept
• Teledoc Telehealth Platform
• Grandsenior Senior Marketplace

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Seven partnerships are on record, tiered core.

• Napoleon HR-4FcoreStrategic or Co-development PartnerNuclear technology company developing a new concept of gas-cooled fast reactor IV generation. Main goal is hydrogen production. Led by CEO Branislav Hatala with extensive experience in nuclear safety.
• AGORA Pharmaceuticals s.r.o.coreStrategic or Co-development PartnerBiotechnology company founded in 2015 focused on developing new advanced drugs for neurodegenerative diseases, especially Alzheimer's disease.
• Teledoc (Jsme Teledoc)coreStrategic or Co-development PartnerPlatform enabling communication between doctors, therapists, volunteers, and those who need help. Addresses problems with doctor shortages and growing mental health issues.
• Grandsenior s.r.o.coreStrategic or Co-development PartnerOnline marketplace cooperating with retirement homes, helping elderly people access products and services for quality living including healthy food, hygiene products, medical supplies, and travel.
• Medical Meadow a.s.coreStrategic or Co-development PartnerMedical division of FABA CAPITAL providing premium medical care in surgery, dentistry, general practice, gynecology, and assisted reproduction.
• FABA INCUBE a.s.coreStrategic or Co-development PartnerStartup incubator helping universities and research institutions apply primary research to industry or business, focusing on innovative ideas, patents, and projects from European grant programs.
• Fetus, IVF a.s.coreStrategic or Co-development PartnerAssisted reproduction company with patented miRNA technology for predicting women's readiness for IVF and selecting suitable embryos to increase IVF success rates.

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Direct peers

• Credo Ventures: Prague-headquartered venture capital firm investing in ambitious CEE founders across Central Europe. Highly comparable as a CEE-focused, regionally-rooted VC competing for the same deal flow and limited partner base as Faba Capital.
• Pale Fire Capital: Czech Republic-based VC firm investing across CEE into early-stage startups. Comparable in geography, fund size, and stage focus, and a direct competitor for the same regional portfolio opportunities Faba targets.
• Day One Capital: CEE-focused early-stage venture capital investor with offices in Budapest and presence across the region. Directly comparable on regional focus, stage, and target portfolio company profile to Faba's venture activities.
• Rockaway Capital: Czech investment group operating across multiple verticals with both venture and operating company involvement. Comparable to Faba in its hybrid holding-company + investor model and Central European base.

Emerging players

• SPiCE VC: Tokenized venture capital fund that issues security tokens to provide liquid, fractional access to VC exposure. Comparable to Faba specifically through the token/innovative-VC-market positioning described in the company's short description.

Broad incumbents

• Earlybird Venture Capital: One of Europe's longest-standing venture capital firms with broad sector coverage across technology and digital health. Comparable as a larger incumbent operating in the same general European VC market Faba is addressing.
• Speedinvest: European venture capital firm with multiple sector-focused funds, including deep tech and health. Comparable to Faba as a broader European VC incumbent operating at much larger AUM in partially overlapping categories like healthtech and frontier tech.
• Atomico: European technology venture capital firm founded by Skype co-founder, investing across stages and geographies in Europe. Comparable as a much larger European VC incumbent whose portfolio includes deep tech and healthcare adjacencies that overlap with Faba's verticals.
• Index Ventures: Global venture capital firm investing across stages in technology and life sciences. Comparable as an established global VC incumbent whose life sciences and frontier-tech funds overlap with Faba's biotech (AGORA) and deep tech (NAPOLEON HR-4F) bets.

Others

• Republic: Tokenized investment and private-markets platform enabling broader access to venture and private deals. Comparable to Faba specifically through the token-based access-to-private-markets value proposition highlighted in Faba's "Innovative Token" positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/fabainvest

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Faba